Allergan Plc
(NYSE : AGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.91%170.482.9%$370.14m
ZTSZoetis, Inc. Class A
1.79%128.861.9%$226.71m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
3.86%6.992.0%$96.70m
MYLMylan N.V.
1.54%18.813.2%$91.34m
TXMDTherapeuticsMD, Inc.
-0.89%3.9024.9%$12.76m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
2.17%38.172.0%$5.98m
TAROTaro Pharmaceutical Industries Ltd.
2.05%75.816.5%$3.31m
ABEOAbeona Therapeutics, Inc.
26.04%2.747.6%$1.68m
LFVNLifeVantage Corporation
-2.11%13.953.3%$1.57m
KINKindred Biosciences, Inc.
5.72%7.390.3%$0.78m
JAGXJaguar Animal Health, Inc.
5.81%0.729.8%$0.74m
CPHIChina Pharma Holdings, Inc.
6.49%0.260.1%$0.02m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.